This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.
The Journal of pediatrics, 181, 146-153.e3
Citation
Danne, Thomas; Biester, Torben; Kapitzke, Kerstin; Jacobsen, Sanja H; Jacobsen, Lisbeth V; Petri, Kristin C Carlsson; Hale, Paula M; Kordonouri, Olga. (2017). Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.. The Journal of pediatrics, 181, 146-153.e3. https://doi.org/10.1016/j.jpeds.2016.10.076